Newsroom

Healthcare Pharmaceutical Biotech

Stay informed with the latest in Healthcare, Pharmaceutical and Biotech press releases through our newsroom. Explore breaking updates, industry trends, and insights shaping these vital sectors—all in one place. Whether it’s innovation, regulatory changes, or breakthroughs, our newsroom keeps you connected to the stories that matter most.


Latest Press Releases

UPDATE: Dr. Hamid Abbasi to Lead International Spine Surgery Training Programs in Pakistan and the United Arab Emirates
Healthcare & PharmaceuticalCompany Update

UPDATE: Dr. Hamid Abbasi to Lead International Spine Surgery Training Programs in Pakistan and the United Arab Emirates

November 26, 2025 11:45 AM

Dr. Hamid Abbasi, a US-based neurosurgeon and global leader in minimally invasive spine surgery, will travel to Dubai to participate in the World Federation of Neurosurgical Societies WFNS meeting. Dr. Abbasi will conduct hands-on training sessions focused on two advanced techniques: the Oblique Lateral Lumbar Interbody Fusion OLLIF and Sacroiliac Joint SIJ fusion. These procedures are known for reduced surgical trauma, shorter hospital stays,...

Read more
Hospital Executives Signal 2026 as Strategic 'Reset Year'
Healthcare & PharmaceuticalConferences

Hospital Executives Signal 2026 as Strategic 'Reset Year'

November 26, 2025 11:00 AM

As hospitals across the United States navigate another demanding year, a new Thanksgiving week flash survey from Black Book finds hospital executives increasingly viewing 2026 as a strategic "reset year": a period to stabilize finances, solidify leadership teams, and realize the benefits of recent policy and technology investments. In a rapid-response poll of hospital and health system leaders conducted over the past week and weekend, 71% of...

Read more
Aspire BioPharma Welcomes Dr. Mark J. Jaroszeski as New Scientific Team Member
Healthcare & PharmaceuticalCompany Update

Aspire BioPharma Welcomes Dr. Mark J. Jaroszeski as New Scientific Team Member

November 26, 2025 9:00 AM

Aspire Biopharma Holdings, Inc. (NASDAQ:ASBP) ("Aspire" or the "Company"), a developer of a multi-faceted patent-pending drug delivery technology, has expanded its scientific team with the November 4, 2025 addition of Mark J. Jaroszeski, PhD, a tenured professor in the Department of Medical Engineering at the University of South Florida. Dr. Jaroszeski, who holds a PhD in Engineering Science with a dissertation focused on mechanically...

Read more
Sinceri Senior Living Announces Strategic Expansion & Continued Growth Across Key Markets
Healthcare & PharmaceuticalMergers and Acquisitions

Sinceri Senior Living Announces Strategic Expansion & Continued Growth Across Key Markets

November 26, 2025 9:00 AM

Sinceri Senior Living is pleased to announce the continued expansion of its national foot, print through the transition and management of additional senior living communities across multiple states. The communities are owned by Ventas, Inc., one of the world's preeminent owners of senior housing. This strategic growth reflects Sinceri's commitment to strengthening its presence in key markets, expanding access to its signature care and service...

Read more
Sannabis, Inc. (OTC: USPS) Announces Binational Hemp Block Initiative Designed to Strengthen U.S.-Colombia Relations Through Sustainable Industrial Development
Healthcare & PharmaceuticalCompany Update

Sannabis, Inc. (OTC: USPS) Announces Binational Hemp Block Initiative Designed to Strengthen U.S.-Colombia Relations Through Sustainable Industrial Development

November 26, 2025 8:45 AM

Sannabis, Inc., f/k/a Ultimate Sports, Inc. (OTC:USPS), a U.S. Company (the "Company") planning to acquire Sannabis S.A.S ("Sannabis") in Colombia, is pleased to announce plans to construct two industrial hemp block manufacturing plants-one in Barranquilla, Colombia, and another in Central Georgia, USA-to produce next-generation structural hemp blocks engineered with up to 33+ MPa load-bearing resistance. To the Company's knowledge, no other...

Read more
VSee Health, Inc. Announces Pricing of $6.0 Million Private Placement Priced At-the-Market Under Nasdaq Rules with a Single Institutional Investor
Healthcare & PharmaceuticalRegulatory

VSee Health, Inc. Announces Pricing of $6.0 Million Private Placement Priced At-the-Market Under Nasdaq Rules with a Single Institutional Investor

November 26, 2025 8:29 AM

VSee Health, Inc. (NASDAQ:VSEE), a leader in innovative telemedicine solutions, today announced that it has entered into a securities purchase agreement with a single institutional investor for the purchase and sale of 9,836,065 shares of common stock (or common stock equivalents in lieu thereof) and warrants to purchase up to 19,672,130 shares of common stock at an effective combined price of $0.61 per share and common warrant for aggregate...

Read more
Wellgistics Health Announces Sponsorship of Dream Bowl 2026 and Participation in DataVault AI Dream Bowl 2026 Meme Coin Shareholder Distribution Plan
Healthcare & PharmaceuticalCompany Update

Wellgistics Health Announces Sponsorship of Dream Bowl 2026 and Participation in DataVault AI Dream Bowl 2026 Meme Coin Shareholder Distribution Plan

November 26, 2025 7:45 AM

Wellgistics Health, Inc. ("Wellgistics") (NASDAQ:WGRX), a health information technology leader implementing EinsteinRx™ artificial intelligence prescription routing for the physical dispensing of prescription drugs with PharmacyChain™ blockchain-enabled smart contracts to optimize the tracking, dispending and insurance coverage of prescription pharmaceutical drugs from manufacturer to dispensing from pharmacy to patient, today announced that it...

Read more
DC Healthcare Returns to Profitability with RM3.06 Million PBT in Q3 FY2025
Healthcare & PharmaceuticalCompany Update

DC Healthcare Returns to Profitability with RM3.06 Million PBT in Q3 FY2025

November 25, 2025 11:40 PM

DC Healthcare Holdings Berhad ("DC Healthcare" or the "Group"), a medical aesthetic services provider specializing in the provision of non-invasive and minimally invasive procedures, delivered a robust performance for the third quarter ended 30 September 2025 ("Q3 FY2025"), achieving a return to profitability with a Profit Before Tax ("PBT") of RM3.06 million for the quarter. The Group posted revenue of RM25.72 million in Q3 FY2025, up 62.7%...

Read more
CureVac Announces Voting Results of Extraordinary General Meeting
Healthcare & PharmaceuticalShareholder Meeting

CureVac Announces Voting Results of Extraordinary General Meeting

November 25, 2025 7:05 PM

CureVac N.V. (Nasdaq:CVAC)(CureVac or the Company), a pioneering multinational biotech company developing a new class of transformative medicines based on messenger RNA (mRNA), today announced the voting results of its Extraordinary General Meeting (EGM). CureVac's shareholders approved all proposals relating to BioNTech SE's public exchange offer for all outstanding shares in CureVac (Offer) at the EGM with an approval rate of over 99.16% of...

Read more
Onco-Innovations Attends University of Alberta's 2025 Innovation Awards
Healthcare & PharmaceuticalCompany Update

Onco-Innovations Attends University of Alberta's 2025 Innovation Awards

November 25, 2025 4:30 PM

Onco-Innovations Limited (CBOE CA:ONCO)(Frankfurt:W1H, WKN:A3EKSZ)(OTCQB:ONNVF) ("Onco" or the "Company") is pleased to announce that it was invited to attend the University of Alberta's 2025 Innovation Awards in Edmonton, Alberta, which were held on November 21, 2025. The annual ceremony is meant to recognize outstanding research and innovation that can translate university discoveries into societal and commercial impact. This year marked the...

Read more
Dr. Hamid Abbasi to Lead International Spine Surgery Training Programs in Pakistan and the United Arab Emirates
Healthcare & PharmaceuticalCompany Update

Dr. Hamid Abbasi to Lead International Spine Surgery Training Programs in Pakistan and the United Arab Emirates

November 25, 2025 4:00 PM

Dr. Hamid Abbasi, a US-based neurosurgeon and global leader in minimally invasive spine surgery, will travel to Dubai to participate in the World Federation of Neurosurgical Societies WFNS meeting. Dr. Abbasi will conduct hands-on training sessions focused on two advanced techniques: the Oblique Lateral Lumbar Interbody Fusion OLLIF and Sacroiliac Joint SIJ fusion. These procedures are known for reduced surgical trauma, shorter hospital stays,...

Read more
Forest Mountain Farms CBD Gummies Introducing Farms CBD Gummies Natural Anxiety Relief & Joint Pain Relief For Better Sleep 2025
Healthcare & PharmaceuticalAdvertorial

Forest Mountain Farms CBD Gummies Introducing Farms CBD Gummies Natural Anxiety Relief & Joint Pain Relief For Better Sleep 2025

November 25, 2025 3:30 PM

Struggling to solve different health issues at the same time, but don't know how? Then, you must try Forest Mountain Farms CBD Gummies, which are new and help in solving stress, pain in the body and many other health problems at the same time. Are you not healthy and constantly facing various health issues like poor sleeping quality, anxiety, chronic pain, depression, stress, and many more? Is your life disturbed due to these health issues that...

Read more
President Trump Expected to Remove Cannabis Barriers to MMJ Research and Drug Development
Healthcare & PharmaceuticalCompany Update

President Trump Expected to Remove Cannabis Barriers to MMJ Research and Drug Development

November 25, 2025 1:35 PM

As Congress moves decisively to eliminate intoxicating hemp products and President Trump prepares to announce a national cannabinoid regulatory directive, MMJ International Holdings, Inc. stands alone as one U.S. company with a fully manufactured, validated, federally compliant cannabinoid pharmaceutical drug ready for FDA clinical trials pending final DEA authorization. With sweeping new federal restrictions-including bans on Delta-8, THC-O,...

Read more
A Future Reimagined Through Choice, Trust and Empowerment
Healthcare & PharmaceuticalEnvironmental, Social and Governance

A Future Reimagined Through Choice, Trust and Empowerment

November 25, 2025 12:50 PM

For Franz Nolan, hearing the words "kidney failure" brought back difficult memories. His father's long struggle with kidney disease made the idea of dialysis feel overwhelming. "I'd just die," he told his wife, Sheree. But Sheree, a DaVita facility administrator, refused to let that be the end of the story. She saw a different future for Franz - one built not on fear, but on knowledge, choice and trust. She asked him to try just one treatment....

Read more
Robotic Surgery and the Future of Precision Medicine
Healthcare & PharmaceuticalCompany Update

Robotic Surgery and the Future of Precision Medicine

November 25, 2025 11:15 AM

Robotic surgery is transforming the landscape of modern medicine. With the integration of robotics and advanced imaging, surgeons can now perform complex procedures with unmatched precision, flexibility, and control, often through tiny incisions and with minimal trauma to surrounding tissues. At the forefront of this movement is Liv Hospital, where highly skilled teams utilize robotic systems to offer patients quicker recovery, reduced...

Read more
Medical Care Technologies Inc. (OTC Pink:MDCE) Strengthens Foundational AI Infrastructure as Company Prepares for Next Development Milestones
Healthcare & PharmaceuticalCompany Update

Medical Care Technologies Inc. (OTC Pink:MDCE) Strengthens Foundational AI Infrastructure as Company Prepares for Next Development Milestones

November 25, 2025 9:30 AM

Medical Care Technologies Inc. (OTC Pink:MDCE) today confirmed that it has initiated the next stage of infrastructure preparation and early system testing to support the long-term scalability of its AI-driven health analytics platform. With AI capabilities advancing rapidly, MDCE is focused on creating a flexible, future-proof structure that enables continuous refinement of its technologies. This includes preparing both the Clinical AI Division...

Read more
Mann Eye Institute Announces Its Holiday Luxury Showcase: An Exclusive Evening of Designer Eyewear
Healthcare & PharmaceuticalCompany Update

Mann Eye Institute Announces Its Holiday Luxury Showcase: An Exclusive Evening of Designer Eyewear

November 25, 2025 9:14 AM

Mann Eye Institute is kicking off the season in style with its Holiday Luxury Showcase, a one-night-only event on Wednesday, Dec. 3, from 5-8 p.m. The celebration will take place at the practice's flagship Houston location at 5115 Fannin Street, 10th Floor. The showcase brings together an elevated collection of high-end frames and sunglasses from some of the most sought-after luxury and designer brands. Guests can explore new arrivals, seasonal...

Read more
VSee Health's iDoc Division Powers Ahead: Delivering on Major Contracts and Igniting Revenue Growth!
Healthcare & PharmaceuticalCompany Update

VSee Health's iDoc Division Powers Ahead: Delivering on Major Contracts and Igniting Revenue Growth!

November 25, 2025 8:18 AM

VSee Health, Inc. (NASDAQ:VSEE), a leader in innovative telemedicine solutions, today announced exciting progress in implementing and fulfilling its previously announced contracts through its iDoc platform. Unlike many public companies that simply tout new deals without follow-through, VSee Health is proving its commitment by actively activating hospitals, scaling services, and driving real revenue growth from existing partnerships. This...

Read more
Telomir Pharmaceuticals Reports New Data Showing Telomir-1 Significantly Reduces PSA Levels in Human Prostate Cancer Cells
Healthcare & PharmaceuticalCompany Update

Telomir Pharmaceuticals Reports New Data Showing Telomir-1 Significantly Reduces PSA Levels in Human Prostate Cancer Cells

November 25, 2025 8:00 AM

Telomir Pharmaceuticals, Inc. (NASDAQ:TELO) ("Telomir" or the "Company"), a preclinical-stage biotechnology company developing therapies that target epigenetic and metabolic drivers of cancer and age-related disease, today reported new preclinical findings demonstrating that its lead therapeutic candidate, Telomir-1, reduced PSA (prostate-specific antigen) levels in androgen-responsive human prostate cancer cells (LNCaP). PSA is one of the most...

Read more
UniDoc Receives Order for Health Cubes
Healthcare & PharmaceuticalCompany Update

UniDoc Receives Order for Health Cubes

November 25, 2025 8:00 AM

UniDoc Health Corp. (CSE:UDOC)(FRA:L7T)(OTCQB:UDOCF) ("UniDoc" or the "Company") is pleased to announce the sale of three Health Cubes to Verizon for demonstration within Verizon Innovation Labs. Two units have been delivered and installed - one at Verizon's Los Angeles Innovation Lab and one at the San Francisco Innovation Center. Verizon plans to use the systems to showcase UniDoc's clinician‑assisted virtual care capabilities to enterprise...

Read more

Join the thousands of ACCESS Newswire customers today who are getting millions of views on their news.


Check out our flexible subscription and pay as you go pricing

and packages.

Use Code NEWS10 for 10% off  of your first purchase.


Latest Blog Posts

Visit our blogs for press release tips, media engagement

Strategies, and Product Comparisons.

Executive delivering prepared remarks from an earnings call script
By Jennifer Hammers • July 9, 2026
How to write earnings call prepared remarks that land — structure, length, the safe-harbor open, non-GAAP language, and building remarks around your strategy.
IR
By Brian Balbirnie • July 8, 2026
A practical earnings call preparation checklist for IR teams — the two-week runway, consensus, logistics, Q&A prep, and Reg FD-clean disclosure timing.
ACCESS Newswire guide on AI investor relations — how AI assistants read company earnings disclosures
By Jennifer Hammers • July 6, 2026
AI assistants read your earnings within minutes. Learn how IR teams make disclosures AI-readable — and how the LLM Citation Score measures your visibility.
A logo for accesswire next to a logo for rack
By Jennifer Hammers • June 21, 2026
Compare Muck Rack vs ACCESS Newswire on pricing, features, and alternatives. See how ACCESS Newswire adds distribution, pitching, and analytics.
A blue and white logo with a check mark next to it
By Jennifer Hammers • June 19, 2026
Compare Business Wire vs ACCESS Newswire on pricing and capabilities — and how ACCESS delivers comparable reach at a fraction of the cost.
A blue background with the word access on it
By Jennifer Hammers • June 14, 2026
Compare ACCESS Newswire vs Cision PR Newswire on pricing, features, reach, and reviews — and why companies are making the switch..
Show More




Discover the news
by Industry:


Need help with your PR Strategy?
Learn more about our
professional PR Services today:

.MEDIA PRO 
Want to get noticed
by the Media but don’t
know how? 

.TOTAL PRO

Need full support to 

Optimize your PR

Efforts?